GenomOncology is a software company based in Cleveland, Ohio that provides the healthcare community with data-driven insights aimed at improving cancer care. GenomOncology specializes in precision oncology, transforming complex and often unusable clinical and molecular data into actionable treatment options and strategic insights for oncology programs.
Their core offering includes software solutions that help healthcare organizations, such as hospitals, cancer centers, and laboratories, make better use of genomic and clinical data. By converting raw data into clear, evidence-based recommendations and insights, GenomOncology empowers clinicians and researchers to identify optimal cancer treatments and improve patient outcomes.
A key differentiator for GenomOncology is its ability to integrate disparate and complex data sources into a unified platform, enabling precise therapy and clinical trial matching. This supports healthcare providers in delivering personalized oncology care and drives measurable improvements within precision oncology programs.
How was GenomOncology started?
GenomOncology was founded by a team of professionals with deep expertise in software development, healthcare data, and precision oncology. The founding team includes individuals with backgrounds in executive leadership, application design, healthcare informatics, business development, and biomedical engineering. For example, Brad Wertz—previously President and COO at Rosetta—and Ian Maurer, who brings over 17 years of software engineering experience, helped shape the company's focus on data-driven healthcare solutions. Other team members, such as Hillary Bedell, PhD, and James Cole, PhD, contribute specialized knowledge in biomedical engineering and precision oncology software. You can read more about their leadership and story on their About page.
Who uses GenomOncology?
GenomOncology primarily serves healthcare organizations involved in cancer care, including:
- Cancer centers
- Hospitals
- Clinical laboratories
- Research institutions
These customers use GenomOncology’s platform to support precision oncology programs, streamline pathology workflows, and enhance data interpretation for personalized cancer treatment decisions. (Specific customer names are not publicly listed.)
What sets GenomOncology apart?
GenomOncology stands out for its focus on turning complex, unstructured data into actionable insights for oncology, as well as its experienced leadership team with backgrounds in healthcare technology, software development, and precision medicine. Their platform not only helps clinicians select appropriate therapies but also provides strategic analytics for program improvement.
Where is GenomOncology located, and how big is the company?
GenomOncology is privately held and headquartered in Cleveland, Ohio, United States, with a team size of 11-50 employees.
Use PromptLoop to Uncover Company Data
Looking for more company insights like this? PromptLoop helps you go deeper, providing unique data points and analysis on companies like GenomOncology and many others. Automate your research and find the information that matters most. Discover how PromptLoop can accelerate your market intelligence. Get A Free Demo to learn more.